Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial

Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Version 86 (2026-02-13) adds Contacts/Locations and Study Status to the record history, and the 2026-02-02 entry was removed.
    Difference
    0.2%
    Check dated 2026-02-18T03:09:28.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page history. Removed the funding-lapse notice and the prior Revision: v3.4.1 banner.
    Difference
    0.3%
    Check dated 2026-02-11T01:56:17.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Contacts/Locations and Study Status have been added, providing current trial locations and status details. A site-wide government funding notice has also been added, and the previous revision v3.4.0 was deleted.
    Difference
    0.5%
    Check dated 2026-02-03T23:29:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The glossary visibility was added and color-coded change indicators were described; the No FEAR Act Data label and revision tag were updated from v3.3.4 to v3.4.0.
    Difference
    0.4%
    Check dated 2026-01-27T23:57:02.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the page history, replacing the previous v3.3.3. This is a minor maintenance update with no impact on trial data or user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:15:27.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Latest version adds a 'Study Status' entry and updates revision metadata (Revision: v3.3.3, 2025-12-22). The earlier revision removed the 'HHS Vulnerability Disclosure' link (2025-11-13, Revision: v3.3.2).
    Difference
    0.2%
    Check dated 2025-12-23T09:18:13.000Z thumbnail image

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.